课题基金 / 基金详情

Dissecting ADP-ribosylation as an innate immune response countering influenza virus replication

Dissecting ADP-ribosylation as an innate immune response countering influenza virus replication
剖析 ADP-核糖基化作为对抗流感病毒复制的先天免疫反应
批准号:
10493284
负责人:
Andrew Mehle
金额:
$19.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-22 至 2024-08-31

项目摘要

项目成果

Andrew Mehle的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Viral infections manipulate diverse post-translational modifications (PTMs), altering existing protein landscapes to create cellular environments favorable to replication. PTMs allow for rapid modulation of host environments by altering protein abundance, localization, and activity. Because of their dynamic nature, PTMs typify ideal immune response effectors or initiators. Our data identifies ADP-ribosylation, the modification of proteins with ADP-ribose (ADPr), as a rapid, immune-like response from infected cells that constitutes an antiviral response that counters influenza virus infection. Using cutting-edge ADPr-specific mass spectrometry approaches, we have characterized with single amino acid resolution the ADP-ribosylome during influenza virus infection and identified thousands of modifications on viral and host proteins. ADP-ribosylation has been associated with antiviral responses against multiple viruses. However, little is known about how viral infections trigger this response or the activiral mechanism(s) of ADP-ribosylation and poly(ADPr)-polymerases (PARPs), the enzymes that catalyze addition of ADPr to proteins. Here, we propose studies of ADP-ribosylation during influenza virus infection. We will identify the functional consequences of specific ADPr modifications, and building on our unique ADP-ribosylome dataset, investigate how ADP-ribosylation alters the function of specific viral and host proteins. We will interrogate the cellular pathways responsible for initiating ADP-ribosylation responses, defining the molecular triggers and PARPs that are activated during influenza virus infection. These experiments will elucidate the mechanisms of ADPr-mediated viral inhibition, the factors that trigger this response, and how viruses counter it, establishing ADP-ribosylation as a key aspect of cellular antiviral responses and perhaps as an entirely independent arm of antiviral defenses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RNA:protein interactions that dictate the success of influenza virus infection
  • 批准号:
    10463147
  • 项目类别:
  • 资助金额:
    $68.54万
  • 财政年份:
    2022
  • 负责人:
    Andrew Mehle
  • 依托单位:
RNA:protein interactions that dictate the success of influenza virus infection
  • 批准号:
    10560604
  • 项目类别:
  • 资助金额:
    $68.54万
  • 财政年份:
    2022
  • 负责人:
    Andrew Mehle
  • 依托单位:
Dissecting ADP-ribosylation as an innate immune response countering influenza virus replication
  • 批准号:
    10379628
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2021
  • 负责人:
    Andrew Mehle
  • 依托单位:
Administrative Supplement to Promote Diversity, R00 GM088484-04
  • 批准号:
    8718181
  • 项目类别:
  • 资助金额:
    $1.06万
  • 财政年份:
    2009
  • 负责人:
    Andrew Mehle
  • 依托单位: